Streetbeat News

Analyst Ratings

ETSY

Evercore ISI Group analyst Shweta Khajuria maintains an 'Outperform' rating on Etsy (NASDAQ:ETSY) but has lowered the price target from $105 to $85.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:54 pm

LYFT

BTIG analyst Jake Fuller has reiterated a 'Neutral' rating on Lyft (NASDAQ:LYFT).

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:52 pm

APD

Jefferies analyst Laurence Alexander maintains a 'Hold' rating on Air Products & Chemicals (NYSE:APD) and raises the price target from $300 to $310.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:52 pm

CF

UBS analyst Joshua Spector maintains a Buy rating on CF Industries Holdings (NYSE:CF) and raises the price target from $95 to $99.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:51 pm

TTWO

UBS analyst Eric Sheridan has maintained a Neutral rating on Take-Two Interactive (NASDAQ:TTWO) and raised the price target from $130 to $151.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:50 pm

OSA

Roth MKM analyst Scott Henry maintains a 'Buy' rating on ProSomnus (NASDAQ:OSA) but has lowered the price target from $6 to $4.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:47 pm

AAPL

B of A Securities analyst Wamsi Mohan has reiterated a Neutral rating on Apple (NASDAQ:AAPL) and maintained a price target of $208.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:46 pm

VQS

Alliance Global Partners analyst Brian Kinstlinger has maintained a 'Buy' rating on VIQ Solutions (NASDAQ:VQS), but lowered the price target from $1.25 to $0.5.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:45 pm

LYFT

LYFT shares are trading higher after BTIG noted a healthy trend in 3Q rides and increased its forecast for 2024 numbers.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:42 pm

CYBN

JAGX

PSIL

Billionaire Steve Cohen has invested nearly $19 million in Cybin Inc. (NYSE:CYBN) for psychedelics R&D. A new bill in Congress aims to discourage federal intervention in states that legalize or decriminalize psilocybin mushrooms. Enthea, a healthcare benefits administrator, is expanding its network to include psychedelic-assisted therapies in health benefit plans. Magdalena Biosciences, Jaguar Health (NASDAQ:JAGX) and Filament Health (OTC:FLHLF) are developing plant-based medicines for mental health indications. The AdvisorShares Psychedelics ETF (NYSE:PSIL) opened at $1.70 on Sept. 18, slightly below previous openings.

Portfolio Pulse from Lara Goldstein

September 26, 2023 | 1:28 pm